|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Enterovirus Surveillance -- United States, 1985Fifty-six reports were received from state virology laboratories of nonpolio enterovirus (NPEV) isolates identified in March, April, or May 1985. Coxsackievirus B2 was isolated most frequently (18/56), followed by coxsackievirus A9 and echoviruses 6, 7, and 11, with four each, then echovirus 4 and coxsackievirus B5, with three each. In 1984, the most common isolates were echovirus 9, with 16.7% (266/1,589) of all isolates; echovirus 11, with 9.1%; coxsackievirus B5, with 8.9%; echovirus 30, with 8.3%; coxsackievirus B2, with 7.8%; and coxsackievirus A9, with 7.6%. Reported by Respiratory and Enterovirus Br, Div of Viral Diseases, Center for Infectious Diseases, CDC. Editorial NoteEditorial Note: A retrospective study of CDC's enterovirus surveillance data from 1970 to 1983 shows that NPEV types isolated in March through May (early isolates) are predictive of types likely to be isolated during the peak enterovirus season (1). In this study, the six most frequent early isolates accounted for an average of 59%, and always more than 50%, of isolates in July through December. Reports of early isolates suggest that coxsackieviruses A9, B2, and B5 and echoviruses 4, 6, 7, and 11 are likely to be common isolates this enterovirus season. Reference
Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 08/05/98 |
|||||||||
This page last reviewed 5/2/01
|